News

Ohly announces probiotic yeast

26 Aug 2015

Following its successful cGMP certification and newly confirmed status as an authorised API (Active Pharmaceutical Ingredients) manufacturer, Ohly has announced the release of Auxoferm Saccharomyces boulardii – a probiotic yeast that the company claims is set to transform the efficacy of oral rehydration systems. The latest release will, the company said, have applications dependent on […]

Ohly announces probiotic yeast

woman-bellyache-young-putting-hands-her-stomach-57697678Following its successful cGMP certification and newly confirmed status as an authorised API (Active Pharmaceutical Ingredients) manufacturer, Ohly has announced the release of Auxoferm Saccharomyces boulardii – a probiotic yeast that the company claims is set to transform the efficacy of oral rehydration systems. The latest release will, the company said, have applications dependent on regional legislation that range from API to Food and Feed Supplements.

“Best practice goes hand-in-hand with tireless R&D,” said Fabienne Saadane-Oaks, CEO of the ABF Ingredients group of companies that includes Ohly. “The certification demonstrates that strength perfectly while the launch of Auxoferm Saccharomyces boulardii enhances our portfolio and showcases the latest expression of our commitment to applications that deliver real benefits.”

Auxoferm Saccharomyces boulardii is said to have unprecedented functionality as a yeast-based probiotic that balances the natural intestinal bacteria, while strengthening the immune system and restoring healthy bowel rhythm. The ingredient is claimed to deliver relief and prevention for viral, bacterial and antibiotic-associated diarrhoea. Auxoferm According to the company, Saccharomyces boulardii is resistant to common antibiotics, fights the overgrowth of harmful bacteria and promotes the growth of intestinal microflora.

Key Benefits of Saccharomyces Boulardii are said to include

  • Helps improve digestion
  • Helps treat all kinds of diarrhoea including antibiotic associated diarrhoea
  • Helps treatment of Irritable Bowel Syndrome
  • Supports gut function against food allergies, Crohn’s disease, Salmonella
  • Reduces bloating and gas
  • Lactose Free
  • Gluten Free
  • Suitable for vegetarian and vegan

Auxoferm Saccharomyces boulardii is manufactured through yeast fermentation, separation and a drying process that removes moisture from the yeast to permit room temperature storage and clinical efficacy.